Cargando…

EZH2 Contributes to 5-FU Resistance in Gastric Cancer by Epigenetically Suppressing FBXO32 Expression [Retraction]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404417/ https://www.ncbi.nlm.nih.gov/pubmed/37551312 http://dx.doi.org/10.2147/OTT.S433399

Ejemplares similares

EZH2 contributes to 5-FU resistance in gastric cancer by epigenetically suppressing FBXO32 expression
por: Wang, Chenyu, et al.
Publicado: (2018)

Retraction Note: Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer
por: Tan, Xiao, et al.
Publicado: (2023)

[Retracted] Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug‑resistant human hepatocellular carcinoma cells to 5‑FU
por: Tang, Bo, et al.
Publicado: (2023)

Retraction: ‘HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2’ (2019), by Ye et al.
Publicado: (2023)

FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells
por: Habel, Nadia, et al.
Publicado: (2021)

Retracted: Clinical Significance of EZH2 in Acute Myeloid Leukemia
por: Intelligence and Neuroscience, Computational
Publicado: (2023)

Retracted: lncRNA HOTTIP Recruits EZH2 to Inhibit PTEN Expression and Participates in IM Resistance in Chronic Myeloid Leukemia
por: International, Stem Cells
Publicado: (2023)

Retraction: Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease
por: Herrera-Merchan, A, et al.
Publicado: (2017)

microRNA-130a is an Oncomir Suppressing the Expression of CRMP4 in Gastric Cancer [Retraction]
Publicado: (2023)

Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance
por: Intuyod, Kitti, et al.
Publicado: (2021)

EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing miR-381 Expression
por: Dou, Dongwei, et al.
Publicado: (2019)

Retraction: Multidrug-Resistance Related Long Non-Coding RNA Expression Profile Analysis of Gastric Cancer
Publicado: (2019)

Propofol Suppresses Proliferation, Migration, Invasion and Promotes Apoptosis by Upregulating microRNA-140-5p in Gastric Cancer Cells [Retraction]
Publicado: (2021)

Retraction: Epigenetic silenced miR‐125a‐5p could be self‐activated through targeting Suv39H1 in gastric cancer
Publicado: (2021)

Retracted: METTL3 Accelerates Breast Cancer Progression via Regulating EZH2 m(6)A Modification
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retraction: MicroRNA-410 Suppresses Migration and Invasion by Targeting MDM2 in Gastric Cancer
Publicado: (2022)

Retraction Note: Large tumor suppressor kinase 2 overexpression attenuates 5-FU-resistance in colorectal cancer via activating the JNK-MIEF1-mitochondrial division pathway
por: Yao, Weilong, et al.
Publicado: (2023)

Retraction: Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics
por: Blum, Kenneth, et al.
Publicado: (2015)

RETRACTED ARTICLE: Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer
por: Tan, Xiao, et al.
Publicado: (2020)

Retraction: MicroRNA-137 Contributes to Dampened Tumorigenesis in Human Gastric Cancer by Targeting AKT2
Publicado: (2023)

LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma [Retraction]
Publicado: (2023)

MicroRNA-137 has a suppressive role in liver cancer via targeting EZH2
por: Cui, Shichang, et al.
Publicado: (2022)

Retraction Notice to: A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID
por: Xu, Yun-chao, et al.
Publicado: (2022)

Retraction: SAMMSON drives the self-renewal of liver tumor initiating cells through EZH2-dependent Wnt/β-catenin activation
por: Li, Xiaopeng, et al.
Publicado: (2022)

Retracted: The Effect of Fu's Subcutaneous Needling Combined with Reperfusion Approach on Surface Electromyography Signals in Patients with Cervical Spondylosis and Neck Pain: A Clinical Trial Protocol
por: International, BioMed Research
Publicado: (2023)

Retraction: MicroRNA-371-5p targets SOX2 in gastric cancer
por: Li, Yu-Ji, et al.
Publicado: (2018)

Retracted: Study on the Mechanism of Action of STAT3 in the Drug Resistance of Gastric Cancer Cells
por: Imaging, Contrast Media & Molecular
Publicado: (2023)

MicroRNA-145-5p Inhibits Gastric Cancer Invasiveness through Targeting N-Cadherin and ZEB2 to Suppress Epithelial-Mesenchymal Transition [Retraction]
Publicado: (2023)

Retraction: S100A8 Contributes to Drug Resistance by Promoting Autophagy in Leukemia Cells
Publicado: (2020)

ZFAS1 Promotes Cisplatin Resistance via Suppressing miR-421 Expression in Oral Squamous Cell Carcinoma [Retraction]
Publicado: (2023)

Retraction Notice to: lncRNA ILF3-AS1 promotes proliferation and metastasis of colorectal cancer cells by recruiting histone methylase EZH2
por: Hong, Sen, et al.
Publicado: (2023)

Retraction: ALDH2 and ADH1 Genetic Polymorphisms May Contribute to the Risk of Gastric Cancer: A Meta-Analysis
Publicado: (2022)

Retraction: LncRNA DANCR promotes migration and invasion through suppression of LncRNA-LET in gastric cancer cells
Publicado: (2020)

Retraction: miR-330-5p suppresses glioblastoma cell proliferation and invasiveness through targeting ITGA5
Publicado: (2021)

KDM5C Expedites Lung Cancer Growth and Metastasis Through Epigenetic Regulation of MicroRNA-133a [Retraction]
Publicado: (2023)

Retraction Note: Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway
por: Fu, Xiao, et al.
Publicado: (2023)

MiR-138-5p Inhibits the Proliferation of Gastric Cancer Cells by Targeting DEK [Retraction]
Publicado: (2023)

Effects of age and sex on epigenetic modification induced by an acute physical exercise: Retraction
Publicado: (2018)

Retraction: miR-5089-5p suppresses castration-resistant prostate cancer resistance to enzalutamide and metastasis via miR-5089-5p/SPINK1/ MAPK/MMP9 signaling
por: Wang, Zhi-Chao, et al.
Publicado: (2020)

miR-96-5p Suppresses the Progression of Nasopharyngeal Carcinoma by Targeting CDK1 [Retraction]
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rk4a5cokhnesbnu0v706or00mj